Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 27, 2021

SELL
$0.44 - $0.99 $417,714 - $939,856
-949,350 Closed
0 $0
Q4 2020

Jan 29, 2021

BUY
$0.43 - $0.64 $408,220 - $607,584
949,350 New
949,350 $446,000

Others Institutions Holding CVSI

About CV Sciences, Inc.


  • Ticker CVSI
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 147,794,000
  • Market Cap $4.43M
  • Description
  • CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense,...
More about CVSI
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.